| Comparison of sequential testing and next generation sequencing in advanced lung adenocarcinoma patients–a single centre experience FG Dall’Olio, N Conci, G Rossi, M Fiorentino, A De Giglio, G Grilli, ... Lung Cancer 149, 5-9, 2020 | 32 | 2020 |
| Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis DM Filippini, M Gatti, V Di Martino, S Cavalieri, M Fusaroli, A Ardizzoni, ... International Journal of Cancer 149 (3), 675-683, 2021 | 14 | 2021 |
| Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis E Grassi, S Durante, A Astolfi, G Tarantino, V Indio, E Freier, ... International Journal of Oncology 52 (6), 1972-1980, 2018 | 12 | 2018 |
| Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report F Gelsomino, A Di Federico, DM Filippini, FG Dall’Olio, G Lamberti, ... Clinical Lung Cancer 21 (2), e45-e48, 2020 | 8 | 2020 |
| Searching for novel multimodal treatments in oligometastatic pancreatic cancer DM Filippini, E Grassi, A Palloni, R Carloni, R Casadei, C Ricci, C Serra, ... BMC cancer 20, 1-5, 2020 | 7 | 2020 |
| Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report M Di Marco, R Carloni, S De Lorenzo, E Grassi, A Palloni, F Formica, ... World journal of clinical cases 8 (7), 1241, 2020 | 5 | 2020 |
| Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review E Broseghini, DM Filippini, L Fabbri, R Leonardi, A Abeshi, D Dal Molin, ... Non-coding RNA 9 (1), 9, 2023 | 3 | 2023 |
| Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy A Barcellini, G Fontana, DM Filippini, S Ronchi, M Bonora, B Vischioni, ... Radiotherapy and Oncology 177, 143-151, 2022 | 3 | 2022 |
| Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies S Cavalieri, DM Filippini, A Ottini, C Bergamini, C Resteghini, E Colombo, ... Exploration of Targeted Anti-tumor Therapy 2 (6), 522, 2021 | 3 | 2021 |
| BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure. F Platini, E Ortolan, S Cavalieri, G Massa, DM Filippini, S Alfieri, ... Journal of Clinical Oncology 38 (15_suppl), e18577-e18577, 2020 | 3 | 2020 |
| The EGFR exon 19 mutant L747-A750> P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma A Di Federico, DM Filippini, FG Dall'Olio, N Conci, R Minari, M Tiseo, ... Clinical Cancer Research 26 (2), 518-519, 2020 | 3 | 2020 |
| IL-1 and senescence: friends and foe of EGFR neutralization and immunotherapy D Romaniello, V Gelfo, F Pagano, M Sgarzi, A Morselli, C Girone, ... Frontiers in Cell and Developmental Biology 10, 1083743, 2023 | 2 | 2023 |
| Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area F Taverna, S Alfieri, R Romanò, G Campanini, S Marceglia, F Giardina, ... Oral Oncology 135, 106229, 2022 | 2 | 2022 |
| 1065P A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission S Alfieri, S Marceglia, DM Filippini, C Bergamini, C Resteghini, ... Annals of Oncology 32, S886, 2021 | 2 | 2021 |
| Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report M Di Marco, R Carloni, S De Lorenzo, C Mosconi, A Palloni, E Grassi, ... World Journal of Gastrointestinal Oncology 12 (12), 1456, 2020 | 2 | 2020 |
| Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression E Ferlizza, D Romaniello, F Borrelli, F Pagano, C Girone, V Gelfo, ... Cancers 15 (11), 2970, 2023 | 1 | 2023 |
| A systematic review of diagnostic and prognostic biomarkers for head and neck cancer of unknown primary: an unmet clinical need DM Filippini, E Broseghini, F Carosi, DD Molin, M Riefolo, L Fabbri, ... Diagnostics 13 (8), 1492, 2023 | 1 | 2023 |
| The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma DM Filippini, C Le Tourneau Current Opinion in Oncology 36 (3), 147-154, 2024 | | 2024 |
| Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? S Alfieri, R Romanò, S Marceglia, V De Giorgi, K Peris, P Sollena, ... The Oncologist 29 (5), e699-e707, 2024 | | 2024 |
| Circulating HPV DNA as a potential biomarker to monitor response to the pembrolizumab and vorinostat combination in patients with squamous cell carcinoma of different locations E Jeannot, DM Filippini, C Dupain, M Halladjian, G Marret, C Coutzac, ... Cancer Research 84 (6_Supplement), 2412-2412, 2024 | | 2024 |
